Rhythm Pharmaceuticals, Inc.RYTMNASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank100
3Y CAGR+522.2%
5Y CAGR+149.0%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
+522.2%/yr
Annual compound
5Y CAGR
+149.0%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
95.6x
Strong expansion
Streak
3 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.77 | +7305.6% |
| 2024 | 0.02 | +222.4% |
| 2023 | 0.01 | +0.9% |
| 2022 | 0.01 | -18.1% |
| 2021 | 0.01 | -51.6% |
| 2020 | 0.02 | +46.4% |
| 2019 | 0.01 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |